Hospital financial stress intensified materially as January disclosures revealed the true depth of operating margin erosion across the sector. More than 30% of U.S. hospitals closed fiscal year 2025 with negative operating margins, despite continued growth in outpatient case volume. In many systems, higher volume simply failed to offset escalating labor, compliance, and infrastructure costs.

Labor expenses now account for approximately 55–60% of total hospital operating costs, up from roughly 48% just a decade ago. Contract labor remains stubbornly elevated in anesthesia, nursing, and perioperative staffing, with some systems reporting labor cost inflation exceeding 25–30% compared with pre-pandemic baselines. These pressures disproportionately burden hospital outpatient departments, which carry hospital-level overhead without enjoying hospital-level reimbursement advantages.

Throughout January, multiple regional health systems initiated discreet outreach to ASC operators, physician groups, and private investors to explore outpatient joint ventures, management transitions, or outright divestitures of hospital-owned outpatient assets. Bankers active in the space reported a roughly 40% increase in outpatient asset sale inquiries compared with January 2025, even though relatively few transactions have closed publicly to date.

The underlying economics are difficult to ignore. Hospitals often lose between $1,500 and $3,000 per outpatient surgical case once internal overhead allocation is applied. In contrast, physician-owned ASCs performing identical procedures routinely generate EBITDA margins of 20–35%, even after accounting for anesthesia subsidies, management fees, and compliance costs. January made one reality increasingly clear: divestment is no longer ideological. It is arithmetic.